Clinical Trial

Fisetin in Mild Alzheimer's Disease

Name: Fisetin in Mild Alzheimer's Disease — clinical trial record (NCT07279714)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: FIS-AD

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

This pilot study will evaluate the safety and tolerability of the natural health product, fisetin, in older adults with mild cognitive impairment or mild Alzheimer's disease dementia.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-11.

Status change: Not Yet Recruiting → Recruiting 2026-04-10

Trial Details

NCT Number	NCT07279714
Lead Sponsor	Sunnybrook Health Sciences Centre Collaborators: Sunnybrook Research Institute
Conditions	Alzheimer s Disease, Alzheimer Dementia, Alzheimer Dementia (AD), Alzheimer Disease, Mild Cognitive Disorder, Neurocognitive Disorders, Mild, Neurocognitive Disorder
Enrollment	5 participants
Start Date	2026-01-27
Primary Completion	2026-11 (estimated)
Study Completion	2026-11 (estimated)
Updated on ClinicalTrials.gov	2026-04-13